• Sales growth was 5% measured in local currency and sales amounted to USD 483 million.
• Bracing and supports sales growth was 5% and 5% organic, both measured in local currency.
• Prosthetics sales growth was 6% and 4% organic, both measured in local currency.
• Gross profit amounted to USD 303 million or 63% of sales, compared to USD 323 million or 63% of sales in 2014.
• EBITDA amounted to USD 97 million or 20% of sales. Adjusted EBITDA amounted to USD 99 million or 20% of sales compared to USD 104 million or 20% of sales in 2014.
• Net profit amounted to USD 51 million or 11% of sales compared to USD 59 million or 12% of sales in 2014.
• USD strengthening has had a significant negative impact on reported sales and profits when comparing to prior year results.
• Cash generated by operations amounted to USD 84 million or 17% of sales compared to USD 98 million or 19% of sales in 2014.
• The Board of Directors will propose to the Annual General Meeting in 2016 that the Company pays a cash dividend of DKK 0.12 per share for 2015, equivalent to 16% of net earnings in 2015.
• The Board of Directors will also propose to the Annual General Meeting to reduce the share capital by cancelling 1,892,688 of the Company's own shares.
